The Diabetic
Retinopathy Market Overview And Analysis by Type, Treatment , by End User and Region - Forecast till
2030
The diabetic
retinopathy market is projected to expand USD 6650 mn at a CAGR 6.50% during
the forecast period 2022-2030.
The rapid rise of diabetic patients is
estimated to be the most crucial factor driving the global diabetic retinopathy market. The increasing demand for diagnostic
tests for diabetic retinopathy is estimated to escalate the market growth
additionally. Further, the rise in the geriatric population is projected to
play an important role in developing the global market. The growing favorable reimbursement
policies, technical development, increasing incidence of blindness due to
diabetes are anticipated to propel the market growth during the assessment
period. Besides, the rise in disposable income and the rising concern towards
the vision have led to an increase in expenditure of the individuals to avail
of the treatment. Further, the minimal pain-inducing laser process with fast
recovery is estimated to promote the market further in the coming period.
On
the contrary, the development is restricted by the lack of expertise and
prolonged approval period required for drugs. However, the emergence of
combined therapies, increasing collaboration between the companies, and product
launch is estimated to create a conducive environment, thereby creating
lucrative opportunities for market growth.
Regional Analysis
Based
on the region, the global digital diabetic retinopathy market size is
segmented into North America, Asia-Pacific, Europe, and the Rest of the World
(RoW). As per the analysis, North America is estimated to dominate the global
market and is likely to exercise its force throughout the forecast period. The
most significant factor leading to regional development is the increasing
attention on preventive care for chronic diseases such as diabetes, obesity,
and others. Further, favorable government initiatives, growing awareness among
people are anticipated to develop the regional market additionally. Moreover,
the region has a sufficient budget allotted for research and development, along
with the fast adoption of technology, which is likely to boost the regional
growth of the market.
Europe
is estimated to take the second position owing to the rising cases of diabetes.
Increasing research and development are further estimated to boost the market further.
Also, the increasing technological development in the region is further
expanding the market in the region.
The
APAC region is projected to be the fastest-growing market during the assessment
period. The regional market is majorly driven by the growing geriatric
population, rising chronic patients, and the increasing demand for the cure is
estimated to develop the regional market further. Also, the presence of
emerging economies like India, China, and Japan is likely to make the most
crucial participation in augmenting the regional market. Further, the
developing regions are witnessing a rise in disposable income, leading to the
expansion of the regional market.
The
MEA region is anticipated to acquire the least market share due to the presence
of poor economies. However, increasing health awareness is likely to promote
diabetic retinopathy in the region.
Market Segmentation
The
segment analysis of the global diabetic retinopathy market is done by
treatment, type, and end-user.
The
treatment-based segments of the global diabetic retinopathy market are laser photocoagulation, anti-VEGF drugs, vitreoretinal
surgery, and steroid injection.
The
type-based segments of the global diabetic retinopathy market are non-proliferative and proliferative.
The end-user-based
segments of the global diabetic retinopathy market are ambulatory surgical centers, hospitals, and others.
Key Players
The
renowned players of the global diabetic retinopathy market are Regeneron
Pharmaceuticals, Inc., F.Hoffmann-La Roche AG,
Alimera Sciences, Aurolab, Allergan PLC, Ampio Pharmaceuticals Inc.,
Abbott Laboratories, and others.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment